BCL2 and cancer: By revealing Bcl-2 downregulation as the basic mechanism of action of PMC-A to promote apoptosis, this study also provides supporting evidence for justification of clinical trials based on antisense/SMI strategies directed against Bcl-2 protein in various cancers.